A study of hepatitis C patients with liver fibrosis and hepatocellular carcinoma demonstrated that IL-17F expression was predominantly localized to hepatocytes, suggesting that serum IL-17F in these individuals may originate, at least in part, from hepatocyte-derived production (41). This evidence concerns the gene IL17F and hepatocellular carcinoma.